Presenting the outputs of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia
Soliman N, Haroutounian S, Hohmann AG, Krane E, Liao J, Macleod M, Segelcke D, Sena C, Thomas J, Vollert J,…
International Association for the Study of Pain presidential task force on cannabis and cannabinoid analgesia position statement
Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N and Rice AS Pain (2021) Link to abstract
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam
VanLandingham KE, Crockett J, Taylor L and Morrison G J Clin Pharmacol (2020) Link to abstract We investigated the effects…
Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene
Boks MP, He Y, Schubart CD, Gastel WV, Elkrief L, Huguet G, Eijk KV, Vinkers CH, Kahn RS, Paus T,…
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
Finlay DB, Sircombe KJ, Nimick M, Jones C and Glass M Front Pharmacol (2020) 11: 359 Link to abstract The…
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
Mayo LM, Asratian A, Linde J, Morena M, Haataja R, Hammar V, Augier G, Hill MN and Heilig M Biol…